Cancer Care Parcel Logo

No products in the basket.

Cancer Care Parcel Logo

No products in the basket.

For Everyone Touched By Cancer

Breakthrough Offers New Tailored Treatment Strategies For Children With Leukaemia

Written by Luisa Robbez-Masson on 
30th November, 2017
Updated: 30th January, 2024
Estimated Reading Time: 2 minutes

A team of oncologists and research scientists working across different hospitals and UK universities have recently published a study in the Journal of Clinical Oncology that brings hope to children with Leukaemia.

What Is Leukaemia?

Leukaemia can exist as different types but the majority of cases affecting children are called Acute Lymphoblastic Leukaemia (ALL). ALL manifests itself most often in young children (1 to 4-year-olds) and numbers show that 400 children will be affected each year by this disease in the UK, accounting for one-third of all childhood cancers.

Leukaemia arises when the bone marrow makes too many lymphocytes (a type of white blood cells) that remain immature and never become functional. Mature lymphocytes circulate in the blood and are needed to fight infections as part of a healthy immune system. The leukaemic cells can be targeted by multiple rounds of effective but toxic chemotherapy treatments which are sadly accompanied by terrible side effects for the child’s body. Indeed, this highly toxic treatment can affect fertility and cause heart problems in later life.

Current Treatment Strategies For Children With Leukaemia

The current guidelines that doctors use to predict the chance of each child to remain cancer-free following a round of treatment are to measure how many cancer cells are left in the patient blood. This measurement is used to determine if a child needs to receive more aggressive chemotherapy (and more bad side effects). Doctors have observed that each patient’s cancer is different and some might go into remission whereas some don’t with a similar number of cancer cells left after treatment. This crucial difference lies in the nature itself of cancer. Every person is unique thanks to its own set of genes and chromosomes. That is also true for cancer cells that carry different types of genetic aberrations. This uniqueness has a big impact on how the cancer cell gets affected by the drugs given during chemotherapy.

New Hope For Patients

The implications are huge for little patients! It means that some children could be spared unnecessary rounds of treatment and still get better! On the other hand, doctors also need to identify the children with leukaemia who are likely to relapse in order to carry on with an aggressive treatment as these children have a poorer outcome, with fewer than 6 in 10 surviving longer than five years.

Finding these different categories of ALL patients was the aim of this study and their results are very promising.

The clever trick is to combine information about the patient’s cancer genes (specific gene abnormalities that are often found in leukaemia cells) to the information about the response to the initial treatment. The results were very encouraging in the 3000 patients that were studied over the last 7 years. This new approach, if implemented on the global scale, could see the five-year survival rate of young patients increase significantly, bringing new hope for children with Leukaemia.

Further Reading

To read the full research article:

More information on ALL:

Related Posts

Gifts For Children With Cancer

Related Posts

The importance of the bone marrow microenvironment for the progression of leukaemia.

Leukaemia White and red blood, as well as platelets are derived from haematopoietic stem cells, which live in the bone marrow cavity. People affected by leukaemia present with symptoms arising due to an uncontrolled proliferation of white blood cells which are arrested at different maturation stages depending on the type of leukaemia. This abnormality interferes […]

Read More
Alice King discusses a non-invasive way to improve cancer diagnosis

With the discovery that common cancers may be identified by blood tests, PET would provide a non-invasive approach to confirm a cancer diagnosis.

Read More
Our CEO Doesn’t Just Look After Cancer Care Parcel

Shara's role is Advisory Board Chair and Chief Scientific Officer and is responsible for overseeing the scientific strategy of Optimised healthcare.

Read More
Beware And Be Aware – Cancer Is Not Warfare

Cancer does not need to be unduly given glory as many of us have seen it being done so far. Cancer is just a disease and we need to keep it at that. Labeling it as a fight, losing a battle, winning the war are all attitudes that can bring negativity or false positivity in everyone involved in this, be it the patient, his or her family as well as the treating team.

Read More
1 2 3 4
We strongly advise you to talk with a health care professional about specific medical conditions and treatments. The information on our site is meant to be helpful and educational but is not a substitute for medical advice.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Sign up for more information
3 Days Of Tips For People With Cancer
3 Days Of Tips To Help You Help Your Friend

Newsletter For
Anyone Touched By Cancer
Sustainability Matters
Every purchase, big or small, has a footprint. But sustainability challenges don’t have a quick fix.
Organisation for Responsible Businesses.
Cancer Care Parcel Ltd. Registered in England and Wales.
Trading Address: Highstone House, 165 High Street, Barnet, Herts. EN5 5SU, UK. Registered Office: 7a High Street, Barnet, Herts, EN5 5UE.
Company Number 14415197, VAT number is GB428826076,  EORI number is XI428826076000